Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Risk factors for local and regional recurrence in patients with resected N0-N1 non-small-cell lung cancer, with implications for patient selection for adjuvant radiation therapy.

Lopez Guerra JL, Gomez DR, Lin SH, Levy LB, Zhuang Y, Komaki R, Jaen J, Vaporciyan AA, Swisher SG, Cox JD, Liao Z, Rice DC.

Ann Oncol. 2013 Jan;24(1):67-74. doi: 10.1093/annonc/mds274. Epub 2012 Sep 20.

2.
3.

Nodal stage of surgically resected non-small cell lung cancer and its effect on recurrence patterns and overall survival.

Varlotto JM, Yao AN, DeCamp MM, Ramakrishna S, Recht A, Flickinger J, Andrei A, Reed MF, Toth JW, Fizgerald TJ, Higgins K, Zheng X, Shelkey J, Medford-Davis LN, Belani C, Kelsey CR.

Int J Radiat Oncol Biol Phys. 2015 Mar 15;91(4):765-73. doi: 10.1016/j.ijrobp.2014.12.028.

PMID:
25752390
4.

Stage I nonsmall cell lung cancer. A multivariate analysis of treatment methods and patterns of recurrence.

Harpole DH Jr, Herndon JE 2nd, Young WG Jr, Wolfe WG, Sabiston DC Jr.

Cancer. 1995 Sep 1;76(5):787-96.

5.

Completely resected N1 non-small cell lung cancer: factors affecting recurrence and long-term survival.

Fujimoto T, Cassivi SD, Yang P, Barnes SA, Nichols FC, Deschamps C, Allen MS, Pairolero PC.

J Thorac Cardiovasc Surg. 2006 Sep;132(3):499-506. Epub 2006 Jul 28.

6.

Prognostic impact of lymphovascular invasion compared with that of visceral pleural invasion in patients with pN0 non-small-cell lung cancer and a tumor diameter of 2 cm or smaller.

Tao H, Hayashi T, Sano F, Takahagi A, Tanaka T, Matsuda E, Okabe K.

J Surg Res. 2013 Nov;185(1):250-4. doi: 10.1016/j.jss.2013.05.104. Epub 2013 Jun 22.

PMID:
23830361
7.

Risk factors for tumor recurrence in patients with early-stage (stage I and II) non-small cell lung cancer: patient selection criteria for adjuvant chemotherapy according to the seventh edition TNM classification.

Maeda R, Yoshida J, Ishii G, Hishida T, Nishimura M, Nagai K.

Chest. 2011 Dec;140(6):1494-502. doi: 10.1378/chest.10-3279. Epub 2011 May 26.

PMID:
21622548
8.

Local failure in resected N1 lung cancer: implications for adjuvant therapy.

Higgins KA, Chino JP, Berry M, Ready N, Boyd J, Yoo DS, Kelsey CR.

Int J Radiat Oncol Biol Phys. 2012 Jun 1;83(2):727-33. doi: 10.1016/j.ijrobp.2011.07.018. Epub 2011 Dec 28.

PMID:
22208965
9.

The prognostic factors of resected non-small cell lung cancer with chest wall invasion.

Lee CY, Byun CS, Lee JG, Kim DJ, Cho BC, Chung KY, Park IK.

World J Surg Oncol. 2012 Jan 12;10:9. doi: 10.1186/1477-7819-10-9.

10.

Lymphovascular invasion in non-small-cell lung cancer: implications for staging and adjuvant therapy.

Higgins KA, Chino JP, Ready N, D'Amico TA, Berry MF, Sporn T, Boyd J, Kelsey CR.

J Thorac Oncol. 2012 Jul;7(7):1141-7. doi: 10.1097/JTO.0b013e3182519a42.

11.

Prognostic impact and initial recurrence site of lymphovascular and visceral pleural invasion in surgically resected stage I non-small-cell lung carcinoma.

Yanagawa N, Shiono S, Abiko M, Ogata SY, Sato T, Tamura G.

Eur J Cardiothorac Surg. 2013 Sep;44(3):e200-6. doi: 10.1093/ejcts/ezt309. Epub 2013 Jun 13.

PMID:
23766428
12.

Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer.

Koike T, Koike T, Yoshiya K, Tsuchida M, Toyabe S.

J Thorac Cardiovasc Surg. 2013 Aug;146(2):372-8. doi: 10.1016/j.jtcvs.2013.02.057.

13.

Overall survival and local recurrence of 406 completely resected stage IIIa-N2 non-small cell lung cancer patients: questionnaire survey of the Japan Clinical Oncology Group to plan for clinical trials.

Ichinose Y, Kato H, Koike T, Tsuchiya R, Fujisawa T, Shimizu N, Watanabe Y, Mitsudomi T, Yoshimura M; Japan Clinical Oncology Group..

Lung Cancer. 2001 Oct;34(1):29-36.

PMID:
11557110
14.

Patterns of failure and overall survival in patients with completely resected T3 N0 M0 non-small cell lung cancer.

Gould PM, Bonner JA, Sawyer TE, Deschamps C, Lange CM, Li H.

Int J Radiat Oncol Biol Phys. 1999 Aug 1;45(1):91-5.

PMID:
10477011
15.
16.

Local failure after complete resection of N0-1 non-small cell lung cancer.

Saynak M, Veeramachaneni NK, Hubbs JL, Nam J, Qaqish BF, Bailey JE, Chung W, Marks LB.

Lung Cancer. 2011 Feb;71(2):156-65. doi: 10.1016/j.lungcan.2010.06.001. Epub 2010 Jul 7.

PMID:
20615576
17.

The impact of surgical adjuvant thoracic radiation therapy for patients with nonsmall cell lung carcinoma with ipsilateral mediastinal lymph node involvement.

Sawyer TE, Bonner JA, Gould PM, Foote RL, Deschamps C, Trastek VF, Pairolero PC, Allen MS, Shaw EG, Marks RS, Frytak S, Lange CM, Li H.

Cancer. 1997 Oct 15;80(8):1399-408.

PMID:
9338463
18.

Surgical-pathologic factors affect long-term outcomes in stage IB (pT2 N0 M0) non-small cell lung cancer: a heterogeneous disease.

Hsu CP, Hsia JY, Chang GC, Chuang CY, Shai SE, Yang SS, Lee MC, Kwan PC.

J Thorac Cardiovasc Surg. 2009 Aug;138(2):426-33. doi: 10.1016/j.jtcvs.2008.12.035. Epub 2009 Mar 28.

19.

Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.

Kumar P, Herndon J 2nd, Langer M, Kohman LJ, Elias AD, Kass FC, Eaton WL, Seagren SL, Green MR, Sugarbaker DJ.

Cancer. 1996 Jun 1;77(11):2393-9.

20.

Factors associated with local and distant recurrence and survival in patients with resected nonsmall cell lung cancer.

Varlotto JM, Recht A, Flickinger JC, Medford-Davis LN, Dyer AM, Decamp MM.

Cancer. 2009 Mar 1;115(5):1059-69. doi: 10.1002/cncr.24133.

Supplemental Content

Support Center